Press release
United States Alzheimer's Disease Therapeutics Market Opportunities & Analysis | Major Players 2025 - Eli Lilly and Company, Pfizer Inc., Merck & Co., Inc.
Alzheimer's Disease Therapeutics Market
Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/alzheimers-disease-therapeutics-market?sp
United States: Recent Industry Developments
✅ In September 2025, Biogen launched a Phase III clinical trial for its new monoclonal antibody targeting beta-amyloid plaques, aiming to slow cognitive decline in early-stage Alzheimer's patients.
✅ In August 2025, Eli Lilly completed the acquisition of NeuroVive Therapeutics, strengthening its pipeline of neuroprotective compounds and expanding research capabilities in Alzheimer's disease.
✅ In July 2025, Roche invested $75 million in a U.S.-based Alzheimer's R&D center focused on innovative small-molecule therapeutics and biomarker-driven clinical trials.
✅ In June 2025, AC Immune launched a novel tau-targeting therapeutic candidate in a multi-center Phase II study, exploring its potential to reduce neurofibrillary tangles and improve cognitive outcomes.
Japan: Recent Industry Developments
✅ In September 2025, Eisai Co., Ltd. launched a clinical trial for its anti-amyloid therapeutic in Japanese patients with mild Alzheimer's, integrating AI-assisted imaging for early detection and monitoring.
✅ In August 2025, Takeda Pharmaceutical invested in expanding its Alzheimer's research facility in Osaka, focusing on disease-modifying therapies and biomarker discovery.
✅ In July 2025, Otsuka Pharmaceutical completed the acquisition of a small biotech startup specializing in tau-targeting therapies, enhancing its neurodegenerative disease pipeline.
✅ In June 2025, Sumitomo Dainippon Pharma launched a Phase II trial of a novel combination therapy aimed at cognitive enhancement and neuroprotection for Alzheimer's patients in Japan.
Alzheimer's Disease Therapeutics Market: Drivers
The Alzheimer's disease therapeutics market is witnessing growth due to rising prevalence of Alzheimer's and other neurodegenerative disorders globally, particularly among aging populations. Increasing awareness of early diagnosis and intervention is driving demand for effective treatments that can slow disease progression, improve cognitive function, and enhance patient quality of life. Advances in research on amyloid-beta, tau protein, and neuroinflammation are fueling the development of innovative therapies, including disease-modifying drugs, monoclonal antibodies, and combination treatments. Growing investment from pharmaceutical companies, government initiatives, and public-private partnerships is accelerating drug development and clinical trials. Additionally, the rising burden on healthcare systems and caregivers is creating demand for effective, long-term therapeutic solutions.
Technological innovations in drug delivery, precision medicine, and biomarker-based diagnostics are enhancing treatment personalization and efficacy. Regulatory support and accelerated approval pathways for breakthrough therapies are facilitating faster market access for promising therapeutics. Collaboration between research institutions, biotech firms, and healthcare providers is fostering innovation and knowledge sharing in Alzheimer's research. The increasing focus on early intervention, preventive care, and holistic management approaches is further boosting market adoption. Collectively, these factors are driving sustained growth in the Alzheimer's disease therapeutics market as the global healthcare community seeks effective solutions to address this challenging and widespread condition.
Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/alzheimers-disease-therapeutics-market?sp
Alzheimer's Disease Therapeutics Market: Major Players
Eli Lilly and Company, Pfizer Inc., Merck & Co., Inc., Eisai Co., Ltd., Merz Therapeutics, Otsuka Pharmaceutical Co., Ltd., Alpha Cognition, and Johnson & Johnson Services, Inc., among others.
Segment Covered in the Alzheimer's Disease Therapeutics Market:
➥ By Stage: Early-stage Alzheimer's (Mild), Middle-stage Alzheimer's (Moderate), Late-stage Alzheimer's (Severe)
➥ By Drug Class: Cholinesterase Inhibitors, NMDA Receptor Antagonists, Combination Drugs, Immunotherapy
Research Process:
Both primary and secondary data sources have been used in the Alzheimer's Disease Therapeutics Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.
Most Frequently Asked Questions in the Alzheimer's Disease Therapeutics Market Research Industry:
➠ Who leads the Alzheimer's Disease Therapeutics industry and what's their competitive positioning regarding capacity, performance, and profitability?
➠ What growth opportunities and market challenges do Alzheimer's Disease Therapeutics market vendors face?
➠ Which segments show the highest growth potential and market share distribution?
➠ What factors are driving or limiting Alzheimer's Disease Therapeutics market growth?
➠ What are the dominant sales and distribution strategies in the Alzheimer's Disease Therapeutics industry?
Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=alzheimers-disease-therapeutics-market
Regional Analysis:
⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?sp
✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends
Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release United States Alzheimer's Disease Therapeutics Market Opportunities & Analysis | Major Players 2025 - Eli Lilly and Company, Pfizer Inc., Merck & Co., Inc. here
News-ID: 4213781 • Views: …
More Releases from DataM intelligence 4 Market Research LLP
United States Lithium-Ion Battery Anode Market 2025 | Growth Drivers, Key Player …
Market Size and Growth
Leander, Texas Nov. 17 2025 The Lithium-Ion Battery Anode Market is expected to grow at a High CAGR during the forecast period 2024-2031.
Key Development:
United States: Recent Lithium‐Ion Battery Anode Developments
✅ In 2025, Group14 Technologies raised US$463 million in Series D funding to scale up its silicon‐carbon composite anode (SCC55), targeting higher energy density and faster charging.
✅ In 2025, OCI signed a long‐term deal to supply silane gas…
United States Nanocomposite Market 2025 | Growth Drivers, Key Players & Investme …
Market Size and Growth
Leander, Texas Nov. 17 2025 Nanocomposite market is growing at a CAGR of 15.5% during the forecast period (2024-2031).
Recent Mergers and Acquisitions:
United States: Recent M&A Developments
✅ In October 2025, Thermo Fisher Scientific agreed to acquire Clario (clinical‐trial data management & analytics) for up to US$9.4 billion, strengthening its digital clinical development capabilities.
✅ In October 2025, Merck (MSD) completed the acquisition of Verona Pharma for US$10 billion,…
United States Energy-Efficient Build-Up Welding Market 2025 | Growth Drivers, Ke …
Market Size and Growth
Leander, Texas Nov. 17 2025 Global Energy-Efficient Build-Up Welding Market reached USD 10.6 billion in 2022 and is expected to reach USD 16.7 billion by 2031, growing with a CAGR of 5.8% during the forecast period 2024-2031.
Key Development and M & A
United States: Recent Energy‐Efficient Build-Up Welding Developments
✅ In March 2025, Lincoln Electric announced the integration of Vanair's mobile power equipment (welders, generators) into its work‐truck and…
United States Protein A Resin Market 2025 | Growth Drivers, Trends & Market Fore …
Market Size and Growth
Leander, Texas Nov. 17 2025 The Scar Treatment Market is expected to grow at a High CAGR during the forecast period 2024-2031.
Key Development:
United States: Recent Protein A Resin Developments
✅ In October 2025, Merck (MilliporeSigma in the U.S.) signed a definitive agreement to acquire the chromatography business of JSR Life Sciences, bringing JSR's AmsphereTM Protein A resin technology into its downstream portfolio.
✅ In October 2025, JSR announced the…
More Releases for Alzheimer
Dementia - Alzheimer Disease Market: A Comprehensive Analysis 2030
Dementia and Alzheimer's disease represent significant challenges within the global healthcare sector. These neurological disorders, characterized by progressive cognitive decline, have seen increasing prevalence due to aging populations worldwide. This growing burden has spurred interest in the Dementia - Alzheimer's disease market, encompassing diagnostic tools, treatments, caregiving solutions, and related healthcare services. This article provides an overview of the market, its scope, current trends, and factors driving its expansion.
Data Bridge…
Alzheimer Disease Treatment Market | Allergan, Amgen, Daiichi Sankyo, Eisai
The global alzheimer disease treatment market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the alzheimer disease treatment market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants.
From the perspective of market dynamics, this report explores the factors driving the growth…
United States Alzheimer Drugs Market Insights Deep Analysis 2023-2031
Cognate Life Sciences introduces a report on "United States Alzheimer Drugs Market 2023" with Market Insights Reports, Introduces systematic details in terms of market valuation, market size, revenue estimation, and geographical spectrum of the business vertical. The study also talks about crucial pockets of the industry such as products or services offered, downstream fields, end using customers, historic data figures regarding revenue and sales, market context and more. It conjointly…
Global Alzheimer Market, Global Alzheimer Industry, Covid-19 Impact Global Alzhe …
Alzheimer's is a progressive disease that leads to the death of brain cells, resulting in memory loss, behavioral issues, and disruption the thought processes. The Alzheimer disease is considered fatal. Age and heredity are the two main risk factors for developing Alzheimer's disease. Several other preventable risk factors have been associated to the development of this disease, including diet, environment, and overall general health. A combination of risk factors is…
US Alzheimer Drug Pipeline Analysis
In US, the Alzheimer's disease is the 6th leading cause of death overall and among those aged 65 and above, it is the 5th leading cause of death. While the deaths from major diseases, like heart disease have decreased, the death due to Alzheimer's have increased by more than 60% between 2000 and 2012. The total number of patients having Alzheimer’s disease was 5.4 million in 2012. Out of this,…
Global Alzheimer Market Report: 2015 Edition | Now Available at Researchmoz.us
Researchmoz added Most up-to-date research on "Global Alzheimer Market Report: 2015 Edition" to its huge collection of research reports.
Alzheimer’s disease is defined as an advanced neurological disorder that increasingly deprives patients of their memory and ability to carry out daily activities. As it grows in a human brain, individuals are likely to practice difficulties in linguistic, agility and insight along with negative changes in the character and performance such as…
